DenovAI Biotech vs Insitro
DenovAI Biotech vs Insitro, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: DenovAI Biotech is on 27/100 and Insitro on 62/100.
Where each one leads
DenovAI Biotech
- headcount growth: +123.5% against +10.9%
Insitro
- our overall score: 62/100 against 27/100
- agent readiness: 40/100 against 29/100
- domain rating: 64/100 against 8/100
- headcount: 255 against 11
- LinkedIn following: 42,173 against 1,367
At a glance
| Measure | DenovAI Biotech | Insitro |
|---|---|---|
| What it is | DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics. | Data-driven drug discovery and development company using machine learning and high-throughput biology. |
| Category | Life Sciences, Biotech, Drug Discovery, AI-Driven Protein Design | Healthcare, Drug Discovery, Drug Development, DNA |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2023 | 2018 |
| Headquarters | Rehovot, Israel | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | DenovAI Biotech | Insitro |
|---|---|---|
| Employees | 11 | 255 |
| Headcount growthLast 12 months | +123.5% | +10.9% |
| Total funding | Not published | $243M |
| Latest round | Seed | Series B |
| Valuation | Not published | $7.0B |
| LinkedIn followers | 1,367 | 42,173 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | DenovAI Biotech | Insitro |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 27/100 | 62/100 |
| Traction | 11/100 | 60/100 |
| Team | 30/100 | 50/100 |
| Community | Not published | 8/100 |
| Search visibility | 36/100 | 62/100 |
| Quality | Not published | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (29/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 8/100 | 64/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | DenovAI Biotech | Insitro |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Open source | Yes | No |
DenovAI Biotech vs Insitro: common questions
Which is better, DenovAI Biotech or Insitro?
On our 0-100 score Insitro rates higher (62/100 against 27/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do DenovAI Biotech and Insitro compare on the numbers?
DenovAI Biotech leads on headcount growth (+123.5% against +10.9%). Insitro leads on our overall score (62/100 against 27/100), agent readiness (40/100 against 29/100), domain rating (64/100 against 8/100), headcount (255 against 11), LinkedIn following (42,173 against 1,367).
Read the full DenovAI Biotech review and pricing or the Insitro review and pricing. You can also browse other DenovAI Biotech alternatives we track.